Acelrx Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Acelrx Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Acelrx Pharmaceuticals Inc
Rating: 2.17633325
Author: Trendlyne DVM scores

about

Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamos...

1.32 -0.03 (-2.22%)

238.46% Gain from 52W Low

320.4K

XNAS Volume

XNAS 17 Jul, 2026 5:30 PM (EDT)

Not Eligible

Expensive Valuation

23.3 / 100

Technically Moderately Bullish

63.7 / 100

No estimates available

Acelrx Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Acelrx Pharma Inc Live Stock Price Today, Share Analysis and Chart

Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamos...

238.46% Gain from 52W Low

SWOT Analysis

Acelrx Pharma Inc Live Price Chart

Acelrx Pharma Inc Live Price Chart